Log In
BCIQ
Print this Print this
 

hypothiocyanite/lactoferrin (ALX-009)

Also known as: Meveol

  Manage Alerts
Collapse Summary General Information
Company Alaxia S.A.S.
DescriptionCombination of hypothiocyanite and lactoferrin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation U.S. - Orphan Drug (Treat cystic fibrosis (CF));
EU - Orphan Drug (Treat cystic fibrosis (CF))
PartnerStragen Healthcare Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today